MicroMarvel: Mereo BioPharma - Analysts Favorite By: TalkMarkets January 16, 2024 at 08:59 AM EST Mereo BioPharma develops therapeutics for oncology and rare diseases, with strong buy recommendations and price targets between $4 and $5. Read More >> Related Stocks: Mereo Biopharma Group Plc ADR